ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study of Barzolvolimab in Patients With Prurigo Nodularis

ClinicalTrials.gov ID: NCT06366750

Public ClinicalTrials.gov record NCT06366750. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Patients With Prurigo Nodularis

Study identification

NCT ID
NCT06366750
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Celldex Therapeutics
Industry
Enrollment
140 participants

Conditions and interventions

Interventions

  • Matching Placebo Other
  • barzolvolimab Biological

Other · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 11, 2024
Primary completion
May 31, 2026
Completion
Feb 28, 2027
Last update posted
Jan 29, 2026

2024 – 2027

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
33
Facility City State ZIP Site status
Total Dermatology Birmingham Alabama 35203
Cahaba Dermatology Skin Health Center Birmingham Alabama 35244
Investigate MD, LLC Scottsdale Arizona 85255
Scottsdale Clinical Trials Scottsdale Arizona 85260
Center for Dermatology Clinical Research, Inc Fremont California 94538
Profound Research LLC Oceanside California 92056
Empire Clinical Research Pomona California 91767
University of California San Francisco San Francisco California 94115
University of California, San Francisco San Francisco California 94115
Dermatology Institute & Skin Care Center Santa Monica California 90404
Focus Clinical Research West Hills California 91307
Encore Medical Research Boynton Beach Boynton Beach Florida 33436
Biobrilliance Medical Research Center Hialeah Florida 33106
Encore Medical Research Hollywood Florida 33024
Life Arc Research Centers Corp Miami Florida 33126
University of Miami Miami Florida 33134
Advanced Clinical Research Institute Tampa Florida 33607
Encore Medical Research of Weston Weston Florida 33331
Emory University Atlanta Georgia 30322
Centricity Research Columbus Georgia 31904
Treasure Valley Medical Research Boise Idaho 83706
MetroMed Clinical Trials Chicago Illinois 60614
DS Research of Southern Indiana, LLC Clarksville Indiana 47129
Equity Medical Bowling Green Kentucky 42104
DS Research of Kentucky, LLC Louisville Kentucky 40241
Revival Research Institute, LLC Troy Michigan 48084
Medisearch, LLC Saint Joseph Missouri 64506
Skin Specialists PC Omaha Nebraska 68144
University of New Mexico Department of Dermatology Albuquerque New Mexico 87102
Equity Medical New York New York 10023
Apex Clinical Research Center - Canton Canton Ohio 44718
UC Health Physicians Office Dermatology Cincinnati Ohio 45219
Paddington Testing, PO Philadelphia Pennsylvania 01913
Columbia Dermatology and Aesthetics Columbia South Carolina 29212
International Clinical Research - Tennessee LLC Murfreesboro Tennessee 37130
Dermatology Treatment and Research Center Dallas Texas 75230
Center for Clinical Studies Webster Texas 77598

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06366750, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 29, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06366750 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →